Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Neurorehabilitation Devices Market Report by Product Type (Neurorobotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interface), Application (Stroke, Multiple Sclerosis, Parkinson's Disease, Cerebral Palsy, and Others), End User (Hospitals and Clinics, Cognitive Care Centers, and Others), and Region 2024-2032
... and Region 2024-2032 The global neurorehabilitation devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
... Research Organizations, and Others), and Region 2024-2032 The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a ... Read More
-
Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects ... Read More
-
Multiple Sclerosis Therapies Market Report by Drug (Immunomodulators, Immunosuppressants), Drug Type (Biologic Drugs, Small Molecule Drugs), Route of Administration (Oral, Injectable, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
... multiple sclerosis therapies market size reached US$ 26.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. Multiple ... Read More
-
Auto-Injectors Market Size, Share, & Trends Analysis By Type (Disposable, Reusable), By Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis), By End Use, By Region, And Segment Forecasts, 2024 - 2030
... global auto-injectors market size was estimated at USD 20.59 billion in 2030 and is projected to grow at a CAGR of 14.4% from 2024 to 2030. Rising incidence of anaphylactic shock and other diseases such ... Read More
-
Multiple Sclerosis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Mesenchymal Stem Cells Market - forecast to 2033 : By SOURCE (Bone Marrow-derived, Adipose Tissue-derived, Umbilical Cord Blood-derived, Peripheral Blood, Dental Pulp, Fetal Liver, Lung), APPLICATION (Bone Regeneration, Cartilage Repair, Osteoarthritis Treatment, Myocardial Infarction Treatment, Ischemic Heart Diseases, Immune System Disorders, Inflammatory Disorders, Gastrointestinal Disorders, Neurological Disorders), TYPE (Autologous, Allogeneic), PROCESSING TECHNIQUE (Cell Sourcing & Isolation, Expansion and Sub-culture, Cryopreservation, Differentiation, Characterization), DELIVERY MODE (Intra-articular Injections, Intravenous Infusion), R&D STATUS (Pre-clinical Studies, Clinical Trials - Phase I, Clinical Trials - Phase II, Clinical Trials - Phase III), DIESEASES (Diabetes, Multiple Sclerosis, Liver Cirrhosis, Stroke, Spinal Cord Injury, Respiratory Disorders), THERAPEUTIC APPLICATION (Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicol
... Ischemic Heart Diseases, Immune System Disorders, Inflammatory Disorders, Gastrointestinal Disorders, Neurological Disorders), TYPE (Autologous, Allogeneic), PROCESSING TECHNIQUE (Cell Sourcing & Isolation, Expansion and Sub-culture, Cryopreservation, Differentiation, Characterization), DELIVERY MODE (Intra-articular Injections, Intravenous Infusion), R&D STATUS ... Read More
-
Global Multiple Sclerosis Treatment Market Report and Forecast 2024-2032
... grow at a CAGR of 4.10 % during the forecast period of 2024-2032, driven by advances in understanding individual genetic markers. The market is experiencing robust growth and is expected to reach USD 30.6 billion ... Read More
-
Global Specialty Pharmaceuticals Market 2024-2028
... report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Multiple Sclerosis Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 20850 million by 2030 with a CAGR of 4.8% during review period. Multiple sclerosis (MS) is a demyelinating disease in which the insulating ... Read More
-
Multiple Sclerosis Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The global multiple sclerosis therapeutics market size is expected to grow from USD 30.03 billion in 2023 to USD ... Read More
-
2024 Global: Multiple Sclerosis Therapeutics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is 1475 billion USD in 2022, growing ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Relapsing-Remitting Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Relapsing-Remitting Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Relapsing-Remitting Multiple Sclerosis market report provides current ... Read More
-
Secondary Progressive Multiple Sclerosis (SPMS) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Secondary Progressive Multiple Sclerosis (SPMS), historical and forecasted epidemiology as well as the Secondary Progressive Multiple Sclerosis (SPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Primary Progressive Multiple Sclerosis (PPMS) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Myelin Regeneration in Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... the Myelin Regeneration in Multiple Sclerosis, historical and forecasted epidemiology as well as the Myelin Regeneration in Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Chronic Progressive Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... Progressive Multiple Sclerosis, historical and forecasted epidemiology as well as the Chronic Progressive Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Progressive Multiple ... Read More
-
Medical Exoskeleton Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others), and Geography
... Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare ... Read More
-
Intermittent Catheters Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson’s Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Cord Injuries, Parkinson’s Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), End User (Hospitals, Ambulatory ... Read More
-
Multiple Sclerosis Therapeutics Market - 2024-2031
... forecast period 2024-2031. Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord (central nervous system). With MS, the immune system mistakenly attacks myelin cells. These are the protective covers (sheaths) ... Read More
-
Multiple Sclerosis Therapeutics
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunomodulators, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$13.2 Billion by the ... Read More
-
Multiple Sclerosis Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 21.33 billion in 2023, and the market is now projected to grow from USD 21.16 billion in 2024 to USD 38.94 billion by 2032, exhibiting a CAGR of 7.9% during the forecast ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
Research Assistance
